Verax Biomedical gets FDA OK for platelet PGD test

The FDA has granted Verax Biomedical clearance to label and market its Platelet PGD test as a safety measure for blood platelet transfusions. The $30 assay, which is being marketed by Fenwal globally, takes less than 30 minutes to spot bacterial contamination in platelets prior to transfusion.

View Full Article in:

Mass High Tech (Boston) · Telegram & Gazette (Worcester, Mass.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA